Lower Annual Facility Fees for U.S.-Made Products
Generic drugmakers producing finished dose products or active pharmaceutical ingredients (API) outside the U.S. will pay an annual facility fee between $15,000 and $30,000 higher than that for domestic plants to cover the additional cost of overseas inspections.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.